Evidence map›Paper›PMID 41566301›Full record

ArticleBMC medical education2026

A comparative study of dermatology education in high and low prevalence areas: Kuwait University and the University of Aberdeen.

Lulwa AlMulla

Abstract readComparative Study
In one paragraph

Article in BMC medical education, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Lulwa AlMullaSchool of Medicine, University of Aberdeen, Aberdeen, Scotland, UK. lulualmulla0@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDermatological disease prevalence differs across regions, which may influence how medical schools prioritise dermatology training. Skin cancer predominates in Scotland, while vitiligo is more common in Kuwait. This study compares dermatology curricula at Kuwait University (KU) and the University of Aberdeen (UoA) to examine how local disease prevalence shapes educational focus and student preparedness.

objectivesTo evaluate differences in curriculum content, student confidence, and clinical exposure between KU and UoA, and to assess the global relevance of their dermatology teaching.

methodsA mixed-methods comparative design was used, combining curriculum document analysis, online surveys of final-year medical students, and semi-structured interviews with faculty and residents. Quantitative data assessed knowledge and confidence, while qualitative themes examined adequacy and exposure.

resultsBoth curricula reflected local disease patterns: KU emphasised pigmentary disorders such as vitiligo, while UoA focused on malignant melanoma (MM) and other skin cancers. KU students reported greater confidence with autoimmune and pigmentary conditions, whereas UoA students demonstrated more substantial knowledge of MM and eczema. Both cohorts and faculty identified insufficient dermatology exposure overall.

conclusionsDermatology education at KU and UoA aligns with local prevalence but may limit preparedness for managing conditions common elsewhere. Expanding international electives, case-based learning, and global curricular integration may enhance dermatological competency across regions.

Indexed as

CurriculumDermatologyEducation, Medical, UndergraduateSkin DiseasesFemaleHumansKuwaitMalePrevalenceScotlandStudents, MedicalUniversitiesCurriculum comparisonDermatology educationGlobal health educationKuwait universityMalignant melanomaUniversity of aberdeenVitiligo

Identifiers

PMID41566301
PMCPMC12908256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.